Also known as آسٹیوپوروسس مینجمنٹ
Consultant Physician
F.C.P.S. (Medicine), M.C.P.S (Medicine), M.B.B.S.
Consultant Physician
F.C.P.S. (Medicine), M.C.P.S (Medicine), M.B.B.S.
Diabetologist
M.B.B.S, F.C.P.S. (Medicine) , MD (USA)
Consultant Physician
M.B.B.S., Diploma In Cardiac Rehabilitation, M.C.P.S
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S., M.R.C.P (UK), MRCP SCE Endocrinology and diabetes , PG Endocrinology , Certificate for obesity management
Internal Medicine Specialist
M.B.B.S., M.R.C.P (UK), MRCP SCE Endocrinology and diabetes , PG Endocrinology , Certificate for obesity management
Internal Medicine Specialist
MBBS, MD (USA), MPH (UK), FAHA (USA)
Cardiologist
M.B.B.S., F.C.P.S., MRCP
Endocrinologist
MBBS, MRCP (Diabetes & Endocrinology), CCT (Endocrinology & Diabetes), CCT General Internal Medicine, FRCP
Endocrinologist
MBBS, MRCP (Diabetes & Endocrinology), CCT (Endocrinology & Diabetes), CCT General Internal Medicine, FRCP
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), MRCEM
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures